AAM
Arabesque Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,199
| Closed | -$3.75M | – | 104 |
|
|
2022
Q4 | $3.75M | Buy |
5,199
+1,390
| +36% | +$1M | 1.27% | 21 |
|
|
2022
Q3 | $2.62M | Buy |
3,809
+474
| +14% | +$327K | 1.28% | 11 |
|
|
2022
Q2 | $1.97M | Buy |
3,335
+388
| +13% | +$229K | 1.04% | 42 |
|
|
2022
Q1 | $2.06M | Buy |
+2,947
| New | +$2.06M | 0.71% | 71 |
|
|
2021
Q4 | – | Sell |
-3,306
| Closed | -$2M | – | 200 |
|
|
2021
Q3 | $2M | Buy |
+3,306
| New | +$2M | 0.67% | 68 |
|
|
2020
Q3 | – | Sell |
-5,102
| Closed | -$3.18M | – | 90 |
|
|
2020
Q2 | $3.18M | Buy |
+5,102
| New | +$3.18M | 2.16% | 16 |
|